Privium Fund Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
170,256
-39,744
-19% -$346K 0.33% 37
2025
Q4
$1.57M Buy
210,000
+12,542
+6% +$127K 0.29% 36
2025
Q3
$1.72M Hold
197,458
0.31% 33
2025
Q2
$819K Buy
197,458
+66,458
+51% +$234K 0.18% 37
2025
Q1
$423K Buy
131,000
+10,000
+8% +$47.1K 0.11% 45
2024
Q4
$674K Buy
121,000
+22,500
+23% +$177K 0.15% 39
2024
Q3
$1.06M Buy
98,500
+58,500
+146% +$971K 0.26% 34
2024
Q2
$823K Buy
40,000
+9,000
+29% +$226K 0.21% 48
2024
Q1
$988K Sell
31,000
-2,680
-8% -$68.4K 0.26% 43
2023
Q4
$716K Hold
33,680
0.2% 51
2023
Q3
$429K Buy
+33,680
New +$563K 0.13% 61

Other funds holding FDMT